Merck & Co. Inc.

NYSE: MRK · Real-Time Price · USD
83.98
1.22 (1.47%)
At close: Aug 15, 2025, 12:14 PM

Merck & Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
8.63B 13.24B 14.59B 11.3B 5.58B 6.84B 8.61B 5.66B 9.71B 12.69B 11.14B 9.68B 8.56B 8.1B 10.02B 8.57B 6.98B
Short-Term Investments
599M 447M n/a 50M 40M 252M 168M 718M 680M 498M 103M 453M 372M n/a n/a n/a n/a
Long-Term Investments
616M 463M 575M 357M 280M 252M 1.31B 1.21B 1.29B 1.01B 984M 238M 316M 370M 435M 411M 544M
Other Long-Term Assets
16.77B 16.04B 14.44B 12.7B 12.33B 12B 10.56B 10.19B 10.28B 9.53B 9.58B 10.97B 11.14B 11.58B 11.19B 11.05B 10.49B
Receivables
10.79B 10.28B 11.38B 11.64B 11.37B 10.35B 10.39B 11.03B 10.41B 9.45B 9.48B 9.64B 9.83B 9.23B 8.57B 7.84B 8.23B
Inventory
6.2B 6.11B 6.24B 6.47B 6.51B 6.36B 6.13B 5.93B 5.86B 5.91B 5.61B 5.54B 5.77B 5.95B 7.98B 7.91B 8.58B
Other Current Assets
9.29B 8.71B 8.14B 8.74B 7.95B 8.37B 6.66B 6.64B 6.74B 7.17B 7.22B 6.81B 6.65B 6.99B 4.5B 4.34B 3.12B
Total Current Assets
35.5B 38.78B 40.36B 38.2B 31.45B 32.17B 31.95B 29.98B 33.4B 35.72B 33.56B 32.12B 31.18B 30.27B 31.06B 28.66B 26.91B
Property-Plant & Equipment
24.79B 23.78B 23.45B 23.22B 23.05B 23.05B 22.53B 22.23B 21.76B 21.42B 20.42B 20.06B 19.75B 19.28B 18.57B 18.06B 18.3B
Goodwill & Intangibles
37.44B 38.04B 38.71B 38.15B 38.75B 39.21B 40.38B 40.86B 41.07B 41.47B 42.53B 43.71B 44.28B 44.2B 32.25B 32.49B 34.61B
Total Long-Term Assets
79.62B 78.32B 77.17B 74.42B 74.4B 74.51B 74.77B 74.49B 74.39B 73.44B 73.52B 74.98B 75.48B 75.43B 62.44B 62.02B 63.94B
Total Assets
115.12B 117.11B 117.53B 112.63B 105.85B 106.67B 106.73B 104.47B 107.8B 109.16B 107.08B 107.09B 106.67B 105.69B 93.49B 90.69B 90.85B
Account Payables
3.78B 4.08B 3.59B 3.52B 3.51B 3.92B 3.51B 3.44B 3.68B 4.26B 3.37B 3.48B 3.71B 4.61B 3.37B 3.9B 4.03B
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
1.36B 2.65B 3.15B 3.07B 3.08B 1.37B 887M 2.84B 2.67B 1.95B 1.94B 2.98B 1.21B 2.41B 3.53B 2.49B 7.25B
Other Current Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Current Liabilities
25.17B 28.42B 29.59B 26.06B 25.1B 25.69B 23.09B 23.39B 23.13B 24.24B 23B 23.17B 22.32B 23.87B 23.73B 21.91B 26.36B
Long-Term Debt
33.48B 34.46B 34.98B 34.72B 31.14B 33.68B 33.97B 34.07B 28.07B 28.75B 28.48B 28.68B 30.59B 30.69B 22.91B 24.03B 24B
Other Long-Term Liabilities
6.66B 6.46B 7.54B 7.33B 8.26B 8.79B 7.34B 7.26B 8.24B 8.32B 8.66B 8.95B 9.74B 9.43B 9.47B 9.87B 12.24B
Total Long-Term Liabilities
41.55B 42.31B 43.39B 42.92B 40.33B 43.35B 42.33B 42.33B 37.76B 38.86B 39.56B 40.61B 43.4B 43.56B 33.9B 35.39B 37.45B
Total Liabilities
66.72B 70.73B 72.97B 68.98B 65.42B 69.04B 65.43B 65.73B 60.89B 63.1B 62.56B 63.78B 65.72B 67.44B 57.63B 57.3B 63.81B
Total Debt
34.84B 37.11B 38.13B 37.79B 34.22B 35.05B 34.86B 36.91B 30.75B 30.69B 30.42B 31.66B 31.79B 33.1B 26.44B 26.52B 31.25B
Common Stock
1.79B 1.79B 1.79B 1.79B 1.79B 1.79B 1.79B 1.79B 1.79B 1.79B 1.79B 1.79B 1.79B 1.79B 1.79B 1.79B 1.79B
Retained Earnings
66.1B 63.07B 61.38B 60.19B 56.7B 53.9B 57.08B 54.2B 62.04B 61.08B 59.93B 58.44B 56.25B 53.7B 51.69B 48.78B 48.89B
Comprehensive Income
-4.96B -4.95B -5.37B -5.36B -5.27B -5.16B -4.92B -4.9B -4.88B -4.77B -4.74B -4.33B -4.37B -4.43B -4.59B -4.63B -6.62B
Shareholders Equity
48.34B 46.31B 44.5B 43.58B 40.36B 37.58B 41.25B 38.69B 46.83B 45.99B 44.46B 43.24B 40.88B 38.18B 35.79B 33.29B 26.95B
Total Investments
1.22B 910M 575M 407M 320M 504M 1.47B 1.93B 1.97B 1.51B 1.09B 691M 688M 370M 435M 411M 544M